| Top Reference |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Self Improvement > Stress Management > To Do List, To A Want To Do List - An Easy Technique To Make The Conversion |
|
Top Reference - To Do List, To A Want To Do List - An Easy Technique To Make The Conversion
I don’t like “Have To’s.” I LOVE “Want To’s." The fewer have to’s and the more want to’s I have in a day, th According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product e happier I am. The happier I am, the more energy I have, so upping my want to’s appears to be a good thing f ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in or my life. Here is a technique that works well for me. I am assuming that you write To-Do lists. lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. Let’s say you have a list of 20 items that need to be done in the next week. A few of these items are essenti here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe l, and have to be done by a certain time, whether you feel like doing them or not. These are usually things li d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ke paying bills, buying food, and going to work. My advice is to just do them, assume they won’t be fun, and ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc be rid of them. This article is really about the non time-critical items that remain. Now, you could ap easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi roach your list by using logic and discipline, going down line by line, and making yourself complete every ite nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically m until you reach the bottom… Yuk. Here’s another approach. I find that what my brain considers fun, cha and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ nges from day to day. I’m either in the mood to do something, or I am not. So I take my list of, let’s say 17 ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi tasks, and read through it. On any given day, 2 or 3 of the tasks will “feel” doable, they may look interesti ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ng, or occasionally fun. They call out to me, I think, “Oh, I can do that, no problem”. Those items then beco dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod me my to-do list for the day. So I do them, and I either don’t mind completing them, or it’s even kind of fun cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin . At the end of the day, I cross those items off of my list. The next day I read through my list again. tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ven though my first choice items are gone, I find that another 2-3 feel interesting to me today. They then be t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel come my to-do list for that day. This is repeated each day until, guess what? My master list is complete ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust d. Now, are there items left that never felt doable?. Sometimes, but often not. By giving myself the freedom y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products to choose what appeals to me each day, I often get through my entire list without having to force myself to do . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de anything. Allowing my ‘heart/gut’ to choose which tasks get done each day, creates a better outcome than elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip giving my intellect the job. Have to’s are converted to want to’s , everything is done, and I feel great tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Sexual Positions for Enhanced Orgasms Homeschooling: Answers To The Most Common Misconceptions About Homeschooling
|